formaldehyde has been researched along with lexipafant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dijkhuizen, S; Grool, TA; Hommes, DW; Meenan, J; ten Kate, FJ; Tytgat, GN; van Deventer, SJ; Whittaker, M; Wood, M | 1 |
1 other study(ies) available for formaldehyde and lexipafant
Article | Year |
---|---|
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.
Topics: Animals; Colitis; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Formaldehyde; Injections, Intravenous; Intestinal Mucosa; Leucine; Leukotriene B4; Male; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2 | 1996 |